CGTX — Cognition Therapeutics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Cognition Therapeutics Inc

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, which is in Phase 2 clinical studi… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$1.24
Market Cap$112M
Float82.3M
Shares Outstanding89.5M
vs. Analyst Target+182.3% to analyst PT
Dividend RateNone
Analyst Target Price$3.50 (4 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$10.1M -$98,000 -$6.0M
2021 N/A -$11.7M -$93,000 -$10.7M
2022 N/A $757,000 -$235,000 -$21.1M
2023 N/A -$25.8M -$252,000 -$25.5M
2024 N/A -$34.0M -$266,000 -$33.7M
2025 N/A -$23.5M -$228,000 -$23.2M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$6.7M
Sep 2025 N/A -$4.9M
Dec 2025 N/A -$3.3M
Mar 2026 N/A -$4.6M

Ownership & Float

Insider Ownership2.2%
Institutional Ownership23.6%
Short Float9.7%
% of All Funds Holding0.84%
Number of Funds Holding69

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.11Near-term / short-term trend
Weekly40-Week SMA$1.42Medium-term trend
Weekly80-Week SMA$1.00Cyclical trend (business cycle)
Weekly200-Week SMA$1.43Secular trend (multi-year)
Monthly10-Month SMA$1.41Near-term monthly trend
Monthly20-Month SMA$0.94Medium-term monthly trend
Monthly40-Month SMA$1.27Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$0.60 support 1.90x 8 months ago
$0.40 support 3.96x 9 months ago

Historical Earnings Reactions (19 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 1.03% 0.86% 52.63% 5.72% -1.64%
1 Day -1.37% 0.00% 42.11% 16.94% -32.41%
1 Week 4.95% -2.58% 42.11% 127.47% -22.78%
2 Weeks 26.00% -0.40% 47.37% 315.07% -25.14%
1 Month 21.21% 2.47% 55.56% 270.75% -45.28%

Next earnings: July 26, 2026 (60 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.11% 44.4% 216
Tuesday -0.71% 35.8% 240
Wednesday 0.81% 49.2% 238
Thursday 0.24% 39.4% 231
Friday 0.12% 43.2% 234

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 23.6%

Insider Transactions — Smart Summary

Total insider ownership: 2.2%

12-Month Insider Activity Summary

Total Filings3
Net Value+$32,492.5
Net Shares Change29,175
% of Float0.0%
C-Suite Filings3
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Doyle John Brendan Chief Financial Officer +$11,300 1 1 buy
Caggiano Anthony Chief Medical Officer +$11,100 1 1 buy
Ricciardi Lisa CEO and President +$10,092.5 1 1 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-04-20 – 2026-04-20 3 3 +$32,492.5 3 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-04-20 Ricciardi Lisa CEO and President +$10,092.5 Transaction at $1.10, now +12.7%
2026-04-20 Doyle John Brendan Chief Financial Officer +$11,300 Transaction at $1.13, now +9.7%
2026-04-20 Caggiano Anthony Chief Medical Officer +$11,100 Transaction at $1.11, now +11.7%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Cognition Therapeutics Inc (CGTX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CGTX on Trend Edge →